Sangamo Therapeutics

In News

Sangamo Therapeutics (SGMO) Nasdaq delisting shifts stock to OTCQB market - MSN

MSN - May 03, 2026

Sangamo Therapeutics (SGMO) to Release Earnings on Monday - MarketBeat

MarketBeat - May 04, 2026

Sangamo Therapeutics to be delisted from Nasdaq, trading to move to OTCQB - Investing.com

Investing.com - Apr 29, 2026

H.C. Wainwright Reaffirms Their Buy Rating on Sangamo Therapeutics (SGMO) - The Globe and Mail

The Globe and Mail - Apr 30, 2026

Sangamo Therapeutics, Inc.(OTCPK: SGMO) dropped from S&P TMI Index - marketscreener.com

marketscreener.com - May 08, 2026

Sangamo Therapeutics Announces First Quarter 2026 Earnings Call - The Manila Times

The Manila Times - May 11, 2026

Sangamo Therapeutics (SGMO) Q4 Loss Highlights Deep TTM Deficit Challenging Bullish Profitability Hopes - simplywall.st

simplywall.st - Apr 01, 2026

Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market - Yahoo Finance

Yahoo Finance - Apr 29, 2026

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Short Interest Update - MarketBeat

MarketBeat - May 01, 2026

Sangamo Therapeutics, Inc.(OTCPK: SGMO) dropped from S&P Global BMI Index - marketscreener.com

marketscreener.com - May 08, 2026

Sangamo Therapeutics : Zinc finger fusions and synthetic DNA donor engineering improve the performance of reprogrammed modular integrases at the TRAC locus - marketscreener.com

marketscreener.com - May 12, 2026

Gregory Davis Sells 69,827 Shares of Sangamo Therapeutics (NASDAQ:SGMO) Stock - MarketBeat

MarketBeat - Apr 23, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment